Cellular pathology of multiple system atrophy: a review.
about
Multiple system atrophy: cellular and molecular pathology.Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS studyOculomotor function in multiple system atrophy: clinical and laboratory features in 30 patients.Diagnosis of dementia and treatment of Alzheimer's disease. Pharmacologic management of disease progression and cognitive impairmentClinicopathological study of 35 cases of multiple system atrophy.Widespread microRNA dysregulation in multiple system atrophy - disease-related alteration in miR-96.The pathogenesis of multiple system atrophy: past, present, and future.β-III Tubulin fragments inhibit α-synuclein accumulation in models of multiple system atrophy.Sphincter EMG and differential diagnosis of multiple system atrophy.The pathological basis of semantic dementia.The pathophysiology of parkinsonism in multiple system atrophy.A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliabilityGenetic players in multiple system atrophy: unfolding the nature of the beast.Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophyA brain-targeted, modified neurosin (kallikrein-6) reduces α-synuclein accumulation in a mouse model of multiple system atrophy.Review: Novel treatment strategies targeting alpha-synuclein in multiple system atrophy as a model of synucleinopathyGlial cytoplasmic inclusions are not exclusive to multiple system atrophy.Multiple system atrophy presenting as parkinsonism: clinical features and diagnostic criteriaSignal changes on MRI and increases in reactive microgliosis, astrogliosis, and iron in the putamen of two patients with multiple system atrophyParkinsonism--recognition and differential diagnosis.Combination of alpha-synuclein immunotherapy with anti-inflammatory treatment in a transgenic mouse model of multiple system atrophyImaging of microglia in patients with neurodegenerative disorders.Visual signs and symptoms of multiple system atrophy.Oligodendroglia and Myelin in Neurodegenerative Diseases: More Than Just Bystanders?Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy.Multiple system atrophy: clues from inclusions.MicroRNA-101 Modulates Autophagy and Oligodendroglial Alpha-Synuclein Accumulation in Multiple System Atrophy.Multiple system atrophy: experimental models and reality.Multiple system atrophy: genetic risks and alpha-synuclein mutations.The Relevance of Iron in the Pathogenesis of Multiple System Atrophy: A Viewpoint.The involvement of supratentorial white matter in multiple system atrophy: a diffusion tensor imaging tractography study.Decreased striatal monoaminergic terminals in multiple system atrophy detected with positron emission tomography.TDP-43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions.A case of multiple system atrophy with hyperglycinaemia due to a selective deficiency of glycine transporter mRNA.Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA).Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: evidence from the Baltimore Longitudinal Study of Aging (BLSA).microRNAs in Neurodegeneration: Current Findings and Potential Impacts.
P2860
Q24535446-59133B4D-A440-437F-97EC-650BACB383EFQ24655620-1B2D5940-26EB-4BB4-8C85-78CE42ACB518Q33326684-A2F723E6-3320-4DF7-977B-1BFDF47155D7Q33601574-6577D232-8B8A-4EDC-BAB1-05A95FE5EA5FQ33733668-CD8B8C6E-3A48-4B9D-9EBC-AF04630F7D7EQ33738316-2896D0CD-445A-4D3B-A5A9-12A36A1CB5E2Q34048136-68901CB2-212E-43BF-8151-D0DF162ACE48Q34107278-1E2CB90F-D885-488C-A552-4B6D5013747BQ34324421-98CA17AD-1B66-4372-B666-EA528AC291A2Q34431680-CF088440-7B8B-474C-B2F9-CF5CF00F8524Q35055565-9F886CA9-EDAB-4AA0-A0EA-D850364AD5E5Q35154822-AAD0903A-C7CC-47A8-ADE4-94D6923198F0Q35169246-9EB3635D-B7B2-4165-9E6C-F5C83B91FC5CQ35544737-86D0A940-E1BF-4CFA-AF14-7ED8CA078FB9Q36086721-698BC366-477C-4FE4-839E-CCF9A4F0A9B6Q36672116-46F20165-BC05-4AD5-974A-ED7174726740Q36718211-DE0605B3-9871-488E-940F-C9E03D235461Q36879516-95A923D2-9247-4288-B996-C392F7A98877Q36886473-3D86B0CB-2492-4D71-A98F-5E578572086FQ36902434-C897AD86-D55B-409B-BA24-CB8D59A2ECC6Q37565960-D221764E-968A-45D8-B22A-AD54A6BC338EQ38015834-BE51FFEA-B0A0-492A-97E8-667F98772FC7Q38254318-F5A81A2E-5F4A-4CDB-811B-D05C78F640A9Q38475947-FCD2AD56-D7B5-4E7A-8400-E7E2339846BEQ39405702-F88BCB54-513C-42F3-A72E-FB5B466FD354Q42850927-F7FC6493-003B-4527-9C86-FB3CA7DC2C4DQ44618765-768CEDAC-BD83-4B46-991F-8DA19E070395Q46726761-E488F0A1-C58A-454F-8BE2-4E0B3D1B54D3Q47309944-D0B08A82-4DC6-477D-BD04-7BFA33FAFADDQ47835285-145B2CAF-CD12-4E21-8B47-58573204D9C8Q48028849-70E9B8CA-F155-4948-AA8E-F5414C47C68DQ48192021-3DD13417-24DB-4975-8A92-4FF2C21FA1F6Q48244352-D5E0974F-A06E-4C77-95D5-797A51CF63B9Q48347991-2539C27F-5725-4D32-B708-077BA4C6F16CQ51927017-4A89C8DF-5BF4-4403-B138-92CE5AC2AAE6Q51953568-E8CB04D1-31FC-4999-A16E-9FADB64A4154Q53369663-9A620DFD-9529-436B-A996-0E734CD9A045Q55231712-E79D04CF-9ECE-44D6-B5F0-B317DC634BC3
P2860
Cellular pathology of multiple system atrophy: a review.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Cellular pathology of multiple system atrophy: a review.
@en
type
label
Cellular pathology of multiple system atrophy: a review.
@en
prefLabel
Cellular pathology of multiple system atrophy: a review.
@en
P2860
P356
P1476
Cellular pathology of multiple system atrophy: a review.
@en
P2093
P2860
P304
P356
10.1136/JNNP.57.2.129
P407
P577
1994-02-01T00:00:00Z